Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2013 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for zavedos
Your search for zavidos retrieved no results
Acute mono-megakaryoblastic leukemia associated with extreme thrombocytosis and complex karyotype abnormalities.
Hu R, Li J, Hu Y, Zhang J, Miao M, Zhu K, Liao A, Yang W, Liu Z. Hu R, et al. Am J Case Rep. 2013 May 17;14:157-160. doi: 10.12659/AJCR.889043. Print 2013. Am J Case Rep. 2013. PMID: 23826456 Free PMC article.
Patient: Female, 55Final Diagnosis: Acute leukemiaSymptoms: ThrombocytosisMedication: Idarubicin HCl (Zavedos), PfizerClinical Procedure: -Specialty: Hematology. OBJECTIVE: Adverse effect of drug therapy. ...
Patient: Female, 55Final Diagnosis: Acute leukemiaSymptoms: ThrombocytosisMedication: Idarubicin HCl (Zavedos), PfizerClinical Proced …
[Comparison of the effectiveness of idarubicin (Zavedos) and mitoxantrone (Refador) in induction therapy of acute myeloid leukemia in elderly patients (55-75) (a prospective multicenter randomized study conducted 1998-2000].
Indrák K, Hubácek J, Mayer J, Voglová J, Jarosová M, Krahulová M, Malý J, Faber E, Penka M, Kmonícek M, Jebavý L, Szotkowski T, Knotková R, Hlusí A, Zapletalová J. Indrák K, et al. Vnitr Lek. 2001 Sep;47 Suppl 1:48-56. Vnitr Lek. 2001. PMID: 11693063 Clinical Trial. Czech.
The use of mitoxantrone (Refador, Lachema) is 15x times cheaper per course of treatment than the use of idarubicine (Zavedos, Pharmacia). Autologous peripheral blood stem cells transplantation (APBSC) was carried out only in 4 patients younger than 60. ...
The use of mitoxantrone (Refador, Lachema) is 15x times cheaper per course of treatment than the use of idarubicine (Zavedos, Pharmac …
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients.
Bouabdallah R, Lefrère F, Rose C, Chaïbi P, Harousseau JL, Vernant JP, Castaigne S, Bauduer F, Zini JM, Coso D, Varet B, Robert J, Fenaux P. Bouabdallah R, et al. Leukemia. 1999 Oct;13(10):1491-6. doi: 10.1038/sj.leu.2401522. Leukemia. 1999. PMID: 10516747 Clinical Trial.
We have conducted a phase II outpatient trial testing weekly oral administration of idarubicin (ZAVEDOS-ZVD) alone to determine the rate of objective response and toxicity in poor risk acute myeloid leukemia (AML) patients over 60 years of age. ...
We have conducted a phase II outpatient trial testing weekly oral administration of idarubicin (ZAVEDOS-ZVD) alone to determine the r …